Walter R. Benson
About
In The Last Decade
Walter R. Benson
64 papers receiving 866 citations
Peers
Comparison fields: 5 of 116
- Organic Chemistry 350
- Spectroscopy 155
- Molecular Biology 127
- Pulmonary and Respiratory Medicine 100
- Pharmaceutical Science 88
Countries citing papers authored by Walter R. Benson
This map shows the geographic impact of Walter R. Benson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter R. Benson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter R. Benson more than expected).
Fields of papers citing papers by Walter R. Benson
This network shows the impact of papers produced by Walter R. Benson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter R. Benson. The network helps show where Walter R. Benson may publish in the future.
Co-authorship network of co-authors of Walter R. Benson
This figure shows the co-authorship network connecting the top 25 collaborators of Walter R. Benson. A scholar is included among the top collaborators of Walter R. Benson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter R. Benson. Walter R. Benson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 10 | |
| 3 | A study of cells present in lymph draining from a contact allergic reaction in pigs sensitized to DNFB. | 20 |
| 4 | 1 | |
| 5 | A method for following human lymphocyte traffic using indium-111 oxine labelling. | 51 |
| 6 | 4 | |
| 7 | SNM Drug Problem Reporting System. | 5 |
| 8 | 5 | |
| 9 | 4 | |
| 10 | 13 | |
| 11 | 4 | |
| 12 | 54 | |
| 13 | 5 | |
| 14 | 28 | |
| 15 | 5 | |
| 16 | 3 | |
| 17 | 5 | |
| 18 | The Incidence of Tumors after Treatment with DL-ethionine and N-2-fluorenylacetamide. | 3 |
| 19 | 5 | |
| 20 | 22 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.